Providing patients and health care professionals access to the on-going clinical trials thatare open for patient enrollment
Metastatic Cancer (CALGB 70604): A Randomized, Phase III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer